AG 1295 [Ligand Id: 5914] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL7724 (AG-1295)
  • platelet derived growth factor receptor beta/platelet derived growth factor receptor alpha/Platelet-derived growth factor receptor in Mouse [ChEMBL: CHEMBL2096980] [GtoPdb: 18041803] [UniProtKB: P05622P26618]
There should be some charts here, you may need to enable JavaScript!
  • platelet derived growth factor receptor beta/Platelet-derived growth factor receptor beta in Human [ChEMBL: CHEMBL1913] [GtoPdb: 1804] [UniProtKB: P09619]
  • platelet derived growth factor receptor beta/Platelet-derived growth factor receptor beta in Mouse [ChEMBL: CHEMBL2749] [GtoPdb: 1804] [UniProtKB: P05622]
There should be some charts here, you may need to enable JavaScript!
  • fms related receptor tyrosine kinase 3/Tyrosine-protein kinase receptor FLT3 in Human [ChEMBL: CHEMBL1974] [GtoPdb: 1807] [UniProtKB: P36888]
There should be some charts here, you may need to enable JavaScript!
  • kinase insert domain receptor/Vascular endothelial growth factor receptor 2 in Human [ChEMBL: CHEMBL279] [GtoPdb: 1813] [UniProtKB: P35968]
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
platelet derived growth factor receptor beta/platelet derived growth factor receptor alpha/Platelet-derived growth factor receptor in Mouse (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL2096980] [GtoPdb: 18041803] [UniProtKB: P05622P26618]
ChEMBL Inhibition of endogenous PDGFR in Swiss3T3 fibroblasts B 5.27 pIC50 5400 nM IC50 J Med Chem (2006) 49: 3101-3115 [PMID:16722630]
ChEMBL Inhibitory activity against platelet-derived growth factor receptor tyrosine kinase in Swiss 3T3 cells B 6.4 pIC50 400 nM IC50 J Med Chem (1996) 39: 2170-2177 [PMID:8667360]
platelet derived growth factor receptor beta/Platelet-derived growth factor receptor beta in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1913] [GtoPdb: 1804] [UniProtKB: P09619]
ChEMBL Inhibition of PDGFRbeta B 5.19 pIC50 6500 nM IC50 Bioorg Med Chem Lett (2010) 20: 3177-3181 [PMID:20403693]
ChEMBL Inhibition of PDGFRbeta expressed in human tumor cells B 5.21 pIC50 6200 nM IC50 Bioorg Med Chem (2008) 16: 5514-5528 [PMID:18467105]
ChEMBL Inhibition of PDGFBB-induced PDGFRbeta autophosphorylation in human SF539 cells incubated for 60 mins prior to PDGFBB-induction measured after 10 mins by phosphotyrosine ELISA B 5.21 pIC50 6200 nM IC50 Bioorg Med Chem (2012) 20: 2444-2454 [PMID:22370340]
ChEMBL Inhibition of PDGF-BB-induced PDGFR beta phosphorylation in human SF539 cells overexpressing PDGFR beta pretreated for 60 mins prior to PDGF-BB addition measured after 10 mins by phosphotyrosine ELISA cytoblot analysis B 5.21 pIC50 6200 nM IC50 Bioorg Med Chem (2013) 21: 1312-1323 [PMID:23375090]
platelet derived growth factor receptor beta/Platelet-derived growth factor receptor beta in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2749] [GtoPdb: 1804] [UniProtKB: P05622]
ChEMBL Inhibition of endogenous PDGFRbeta autophosphorylation in Swiss 3T3 fibroblasts B 5.27 pIC50 5400 nM IC50 Bioorg Med Chem (2007) 15: 2187-2197 [PMID:17210255]
fms related receptor tyrosine kinase 3/Tyrosine-protein kinase receptor FLT3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1974] [GtoPdb: 1807] [UniProtKB: P36888]
ChEMBL Inhibition of endogenous FLT3 in EOL1 cells B 5.96 pIC50 1100 nM IC50 J Med Chem (2006) 49: 3101-3115 [PMID:16722630]
ChEMBL Inhibition of endogenous FLT3 autophosphorylation in EOL1 cells B 5.96 pIC50 1100 nM IC50 Bioorg Med Chem (2007) 15: 2187-2197 [PMID:17210255]
kinase insert domain receptor/Vascular endothelial growth factor receptor 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL279] [GtoPdb: 1813] [UniProtKB: P35968]
ChEMBL Inhibition of VEGFR2 in human U251 cells by phosphotyrosine ELISA B 5.21 pIC50 6200 nM IC50 Bioorg Med Chem (2009) 17: 7324-7336 [PMID:19748785]

ChEMBL data shown on this page come from version 34:

Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]